If you have been diagnosed with type 2 diabetes, Consumer Reports has an important message for you: Don’t take Actos.

In conjunction with mounting lawsuits and studies linking the dangerous drug to severe side effects such as heart failure, bladder cancer and bone fractures, the consumer advocacy group issued a public health announcement on August 21, 2012 stating that the newly approved generic version of the drug, pioglitazone, is “one ‘bargain’ to avoid.”

The public health alert was issued shortly after the U.S. Food and Drug Administration (“FDA”) approved the generic version of the popular type 2 diabetes drug, on August 17, 2012.  The approval to market generic Actos tablets in 15 milligram, 30 mg and 45 mg strengths was made despite numerous adverse event reports, mounting litigation and a wave of recent studies linking Actos to bladder cancer – no doubt leaving many unable to comprehend this decision.  If anything, Actos should have been recalled by the FDA, rather than give consumers with a cheaper option of a drug that has been linked to serious side effects. Given the rising concerns associated with the drug, Consumer Reports is urging diabetics to consider using Actos only as a “last resort,” and to instead treat their condition with metformin, another form of medication, either by itself or with glipizide or glimepride.

Notwithstanding the FDA’s decision, those who have developed bladder cancer as a result of taking Actos are continuing to actively file lawsuits. Takeda Pharmaceuticals, the drug’s manufacturer, is currently facing hundreds of lawsuits filed by individuals who have been diagnosed with bladder cancer as a result of using Actos.  Plaintiffs who have brought these cases allege that they developed bladder cancer as a result of taking Actos, and that its manufacturer, Takeda Pharmaceuticals, failed to warn consumers of its risks.

If you developed bladder cancer as a result of using Actos, you may be eligible to file an Actos lawsuit against the manufacturer. The lawyers at Bernstein Liebhard LLP are currently evaluating and investigating claims on behalf of individuals who developed bladder cancer as a result of taking Actos. Learn more about Actos lawsuits by perusing our website or by contacting us directly at (877) 779-1414.

Published September 11, 2012 by